NCT/Study#
NA /
AT148002
A Phase 1/2 Study Of Alx148 In Combination With Azacitidine In Patients With Higher Risk Mds
DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
